Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis

Although direct‐acting antivirals (DAAs) for chronic hepatitis C virus (HCV) infection are highly efficacious and safe, treatment initiation is often limited in patients with neuropsychiatric disorders due to concerns over reduced treatment adherence and drug–drug interactions. Here, we report adher...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Viral Hepat
Auteurs principaux: Back, David, Belperio, Pamela, Bondin, Mark, Negro, Francesco, Talal, Andrew H., Park, Caroline, Zhang, ZhenZhen, Pinsky, Brett, Crown, Eric, Mensa, Federico J., Marra, Fiona
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2019
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6852431/
https://ncbi.nlm.nih.gov/pubmed/30977945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.13110
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires